Arkolith/Insider Trading/QNRX/Form 4

Myers Michael

Chief Executive Officer, DirectorQuoin Pharmaceuticals, Ltd. (QNRX) · full profile →Form 4 · filed Sep 5, 2024
Net Buying
Open-Market Buys
$29K
Open-Market Sells
$0
Net Open-Market Flow
$29K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Sep 4, 2024Buy(P)5K$0.66$4K15K
Sep 4, 2024Buy(P)24K$0.80$19K47K
Sep 4, 2024Buy(P)8K$0.75$6K24K
Sep 3, 2024Buy(P)800$0.62$49610K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-097254) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML